SRSonia Resik

Sonia Resik

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Sonia Resik has a total of 68 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Antiviral activity of a crude extract of Thalassia testudinum Banks ex König against the human enteroviruses echovirus 9 and coxsackievirus A16

    by Liena de R. Ponce Rey, Rafael Frómeta Román, Elizabet Casanova Nodarse, Kethia González García, Luis F. Morier Díaz, Sonia Resik Aguirre, Idania Rodeiro Guerra

    Context: Echovirus 9 (E9) and coxsackievirus A16 (CVA16) are etiological agents of aseptic meningitis and hand, foot, and mouth disease, respectively. Currently, there are no approved antiviral drugs against these viruses. The marine plant Thalassia testudinum represents a potential source of bioactive compounds for the treatment of viral diseases with clinical and epidemiological importance. Aims: To evaluate the in vitro antiviral activity of a hydroalcoholic extract of the marine plant T. testudinum against clinical isolates of echovirus 9 and coxsackievirus A16. Methods: The cytotoxicity of the extract was evaluated in Vero and RD cells via the MTT method. The antiviral activity (EC50) was determined by the inhibition of cytopathic effects. Extracellular virucidal activity and reduction in viral yield were determined via a viral titration assay. The viral genome was quantified after manual extraction and amplified using semi-nested RT-PCR. Results: The extract was non-cytotoxic to Vero or RD cells (CC50 = 3840.96 ± 116.12 µg/mL and 3822 ± 220.5 µg/mL, respectively) and inhibited the virus replication (CE50 = 512.82 ± 22.32 µg/mL and 1367.1 ± 58.66 µg/mL, respectively), verified by the selective index values of 7.48 and 2.79 against echovirus 9 and coxsackievirus A16, respectively. The extract showed extracellular virucidal activity against E9 and reduced the infective titer by more than two logarithms. The CVA16 genome concentration was reduced when the cells were treated with increasing concentrations of the extract, although no significant differences were detected. Conclusions: Thalassia testudinum crude hydroalcoholic extract inhibited the replication of the human enteroviruses E9 and CVA16. These results provide preliminary evidence of the potential of this plant as a source of antiviral compounds.

  • Open Access

    Mortalidad y factores asociados en pacientes cubanos infectados con VIH-1

    by Pablo Carlos Sariol-Resik, Tatiana Prieto-Domínguez, Miguel Angel Blanco-Aspiazu, Sonia Resik-Aguirre, Waldemar Baldoquin Rodríguez

    Objetivo: Determinar las principales causas de muerte y los factores asociados en los pacientes infectados con el VIH ingresados en el hospital del Instituto de Medicina Tropical “Pedro Kourí” durante los años 2017-2018. Métodos: Se realizó un estudio retrospectivo de casos y controles para determinar las causas de la muerte y algunos factores asociados a ella, en el hospital del Instituto de Medicina Tropical “Pedro Kourí”, en el período 2017-2018. Para determinar estos factores se utilizó un análisis multivariado basado en un modelo de regresión logística binaria. Resultados: Las causas de muerte más frecuentes fueron las asociadas al SIDA, fundamentalmente las infecciones oportunistas del sistema respiratorio (41,4%), seguidas por las neoplasias no asociadas al SIDA (25,1%). Los factores que mayor influencia tuvieron sobre la mortalidad fueron la presencia de enfermedad oportunista (OR 14,07 pConclusiones: Las enfermedades asociadas al SIDA, principalmente las infecciones oportunistas del sistema respiratorio, seguidas por las neoplasias no asociadas al SIDA fueron las causas predominantes de muerte en los pacientes infectados con el VIH que fallecieron en el Instituto de Medicina Tropical “Pedro Kourí” durante el período de estudio. La presencia de neoplasias no asociadas al SIDA, de enfermedades oportunistas, de alteraciones de las funciones renal y hepática, el aumento de la carga viral y el tener menos años de diagnóstico al momento del ingreso, fueron los factores que más contribuyeron a la mortalidad en los pacientes ingresados e infectados con el VIH. El modelo matemático resultante se ajustó bien a los datos y explicó de manera consistente los factores asociados a la mortalidad.


  • Open Access

    Performance evaluation of Elecsys SARS‐CoV‐2 Antigen immunoassay for diagnostic of COVID‐19

    by María C. Montalvo Villalba, Elena Sosa Glaria, Licel de Los Ángeles Rodriguez Lay, Odalys Valdés Ramirez, Dayana Vallina García, Amely Arencibia Garcia, Javier Martinez Alfonso, Dunia M. Menes Llerena, Loida Torres Pérez, Sonia R. Resik Aguirre, et al.

    One of the challenges for control and prevention of severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) infection is the early diagnostic at the point of care. Several tests based on qualitative antigen detection have been developed; one of these is Elecsys SARS‐CoV‐2 Antigen immunoassay (Roche Diagnostics). In total, 523 nasopharyngeal swabs were randomly selected with the aims to evaluate sensitivity, specificity, cross‐reactivity, positive and negative predictive value (PPV, NPV), and agreement of Elecsys SARS‐CoV‐2 Antigen immunoassay using reverse transcription‐polymerase chain reaction (RT‐PCR) STAT‐NAT® coronavirus disease‐2019 as reference test. Cross‐reactivity was estimated using samples positive by RT‐PCR to other respiratory viruses (influenza virus, parainfluenza virus, rhinovirus, coronavirus OC43, and HKU1). The overall sensitivity of Elecsys SARS‐CoV‐2 Antigen was 89.72% (288/321); specificity was 90.59% (183/202); and cross‐reactivity to other respiratory viruses were not detected. Elecsys SARS‐CoV‐2 Antigen immunoassay showed a high sensitivity in samples with cycle threshold value κ coefficient was 0.79 (95% confidence interval: 0.73–0.84), showing substantial agreement between both tests. The results suggest Elecsys SARS‐CoV‐2 Antigen immunoassay could be used as an alternative to RT‐PCR testing, or in complement with it, to identify infectious individuals and reduce SARS‐CoV‐2 transmission.


  • Open Access

    Selección del tratamiento de rescate en pacientes con VIH-1: respuesta y supervivencia

    by Tatiana Prieto-Domínguez, Pablo Sariol-Resik, Carlos Miguel Fonseca-Gómez, Sonia Resik-Aguirre, Vivian Kouri-Cardellá, Waldemar Baldoquin-Rodríguez

    Objetivo: Determinar el impacto del uso de la prueba genotípica de resistencia en la respuesta y supervivencia a largo plazo de los pacientes infectados con el VIH-1 que presentaron fracaso a la terapia antirretroviral. Métodos: Se realizó un estudio de cohorte, retrospectivo, se definieron dos grupos basados en la forma de selección de la terapia de rescate utilizada: en base al resultado de la prueba genotípica de resistencia (grupo A) y en base al criterio de expertos (grupo B). Los pacientes fueron evaluados antes del cambio de la terapia de rescate según variables demográficas, clínicas y de laboratorio y evaluados a los 6, 12, 18, y 24 meses del cambio de tratamiento según respuesta virológica, respuesta de células CD4+, incidencia de enfermedades oportunistas y supervivencia. La información fue obtenida de las actas de la Comisión Nacional de Terapia Antirretroviral, la base de datos del IPK y las Historias Clínicas. Se utilizaron números absolutos y porcentajes, media y mediana, con sus respectivas desviaciones estándares (DE), Chi2, se aplicó el Riesgo Relativo (RR), prueba U de Mann-Whitney, y el método de Kaplan-Meier. Resultados: Los pacientes de grupo A tuvieron 1,44 veces mayor probabilidad de alcanzar supresión virológica completa que los pacientes del grupo B a los 6 meses, RR 1,44 (1,046-2,054) p=0,017. El incremento promedio de Linfocitos T CD4+ fue de 117,40 células/mm3 en pacientes del grupo A y de 30,04 células/mm3 en pacientes del grupo B, pConclusiones: Los pacientes en los cuales el tratamiento de rescate se escogió basado en una prueba genotípica de resistencia tuvieron una mejor respuesta virológica, un mayor incremento de Linfocitos T CD4+ y una mayor supervivencia que aquellos en los que el tratamiento se eligió basado en el criterio de expertos.

  • Open Access

    Molecular Characterization of Coxsackievirus A24v from Feces and Conjunctiva Reveals Epidemiological Links

    by Magilé C. Fonseca, Mario Pupo-Meriño, Luis A. García-González, Mayra Muné, Sonia Resik, Heléne Norder, Luis Sarmiento

    Coxsackievirus A24 variant (CVA24v), the main causative agent of acute hemorrhagic conjunctivitis (AHC), can be isolated from both the eyes and lower alimentary tract. However, the molecular features of CVA24v in feces is not well-documented. In this study, we compared the VP1 and 3C sequences of CVA24v strains isolated from feces during AHC epidemics in Cuba in 1997, 2003, and 2008–2009 with those obtained from conjunctival swabs during the same epidemic period. The sequence analyses of the 3C and VP1 region of stool isolates from the three epidemics showed a high degree of nucleotide identity (ranging from 97.3–100%) to the corresponding conjunctival isolates. The phylogenetic analysis showed that fecal CVA24v isolates from the 1997 and 2003 Cuban outbreaks formed a clade with CVA24v strains isolated from conjunctival swabs in Cuba and other countries during the same period. There were three amino acid changes (3C region) and one amino acid change (VP1 region) in seven CVA24v strains isolated sequentially over 20 days from fecal samples of one patient, suggesting viral replication in the intestine. Despite these substitutions, the virus from the conjunctival swab and fecal samples were genetically very similar. Therefore, fecal samples should be considered as a reliable alternative sample type for the routine molecular diagnosis and molecular epidemiology of CVA24v, also during outbreaks of AHC.


  • Open Access

    The Cuba–United States Thaw: Building Bridges Through Science and Global Health

    by Daniel G. Bausch, Vivian Kouri, Sonia Resik, Belsy Acosta, Gerardo Guillen, Karen Goraleski, Marcos Espinal, Maria G. Guzman

    Beginning in 2014, there has been significant progress in normalization of relations between Cuba and the United States. Herein, we discuss the history and recent progress in scientific collaboration between the two countries as well as the continued challenges. Science and global health diplomacy can be key tools in reestablishing a trusting and productive relationship of mutual and global benefit, bringing about better and healthier lives for people in both Cuba and the United States.


  • Reactogenicity and immunogenicity of inactivated poliovirus vaccine produced from Sabin strains: A phase I Trial in healthy adults in Cuba

    by Sonia Resik, Alina Tejeda, Magilé Fonseca, Nilda Alemañi, Manuel Diaz, Yenisleidys Martinez, Gloria Garcia, Hiromasa Okayasu, Anthony Burton, Wilfried A.M. Bakker, et al.


  • Nearly identical strains of human herpesvirus 8 in couples discordant for Kaposi's sarcoma

    by Vivian Kouri, Alessandra Marini, Sandeep Nambiar, Maria E Rodriguez, Virginia Capo, Sonia Resik, Beatriz Mantecon, Ariel Martinez, Karin J Köhler-Hansner, Ulrich R Hengge

    Transmission of human herpesvirus 8 (HHV-8) may occur through various routes including breastfeeding and sexual intercourse. We attempted to detect HHV-8 infection in nine HIV-positive couples discordant for Kaposi's sarcoma who maintained a monogamous sexual relationship for at least one year. By quantitative real-time polymerase chain reaction and HHV-8 genotyping we provide strong evidence for the sexual transmission of HHV-8 in this unique cohort.


    • 27 April 2005
      • Vol. 55  (3) , 213-6

    [Application of SensiScript enzyme to a RT-PCR system for the obtention of RNA of HIV-1 starting serum samples stored at -20 degrees C during a decade].

    by Sonia Resik Aguirre, Li-Hua Ping, Julio A Barrios Olivera, Vivian Kourí Cardellá, Ronald Swanstrom

    The efficiency of SensiScript reverse transciptase to obtain useful genetic material in the sequencing of the nucleic acid from HIV-1, starting from sera collected between 1989 and 1998 and kept at suboptimal temperatures, was proved. On using the SensiScript enzyme it was obtained an amplification of the RNA of the HIV-1 in 86.5 % of the studied samples, compared with 20 % on using the AMV-RT enzyme . No amplification was obtained in 13.5 % of the studied samples with any of the 2 enzymes used.

  • Role of the virology diagnosis laboratory in the surveillance of rubella virusCuba 1988/2000

    by M Delosangelesribas, Miguel Galindo, Gisset Torres, Marlen Valcarsel, Reynel Cancio, Maria Guadalupe Guzmán, Delfina Rosario, Sonia Resik, Carina Rodriguez, Daneb Garcia, et al.